1
|
Kim A, Ueda Y, Naka T and Enomoto T:
Therapeutic strategies in epithelial ovarian cancer. J Exp Clin
Cancer Res. 31:142012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Colombo N, Van Gorp T, Parma G, et al:
Ovarian cancer. Crit Rev Oncol Hematol. 60:159–179. 2006.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Wrzeszczynski KO, Varadan V, Byrnes J, et
al: Identification of tumor suppressors and oncogenes from genomic
and epigenetic features in ovarian cancer. PloS One. 6:e285032011.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Holschneider CH and Berek JS: Ovarian
cancer: epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Shih Ie M and Davidson B: Pathogenesis of
ovarian cancer: clues from selected overexpressed genes. Future
Oncol. 5:1641–1657. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Nelson AE, Francis JE and Zorbas H:
Population screening and early detection of ovarian cancer in
asymptomatic women. Aust NZ J Obstet Gynaecol. 49:448–450. 2009.
View Article : Google Scholar
|
7
|
Trimbos JB, Parmar M, Vergote I, et al;
International Collaborative Ovarian Neoplasm 1 and the European
Organisation for Research and Treatment of Cancer
Collaborators-Adjuvant Chemotherapy in Ovarian Neoplasm.
International collaborative ovarian neoplasm trial 1 and adjuvant
chemotherapy in ovarian neoplasm trial: two parallel randomized
phase III trials of adjuvant chemotherapy in patients with
early-stage ovarian carcinoma. J Natl Cancer Inst. 95:105–112.
2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Aabo K, Adams M, Adnitt P, et al:
Chemotherapy in advanced ovarian cancer: four systematic
meta-analyses of individual patient data from 37 randomized trials.
Advanced ovarian cancer trialists’ group. Br J Cancer.
78:1479–1487. 1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Markman M: Optimizing primary chemotherapy
in ovarian cancer. Hematol Oncol Clin North Am. 17:957–968. 2003.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Ali AY, Farrand L, Kim JY, et al:
Molecular determinants of ovarian cancer chemoresistance: new
insights into an old conundrum. Ann NY Acad Sci. 1271:58–67. 2012.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Mitra S, Cheng KW and Mills GB: Rab25 in
cancer: a brief update. Biochem Soc Trans. 40:1404–1408. 2012.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Agarwal R, Jurisica I, Mills GB and Cheng
KW: The emerging role of the RAB25 small GTPase in cancer. Traffic.
10:1561–1568. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Cheng KW, Lahad JP, Kuo WL, et al: The
RAB25 small GTPase determines aggressiveness of ovarian and breast
cancers. Nat Med. 10:1251–1256. 2004. View
Article : Google Scholar : PubMed/NCBI
|
14
|
Caswell PT, Spence HJ, Parsons M, et al:
Rab25 associates with alpha5beta1 integrin to promote invasive
migration in 3D microenvironments. Dev Cell. 13:496–510. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Liu Y, Tao X, Jia L, et al: Knockdown of
RAB25 promotes autophagy and inhibits cell growth in ovarian cancer
cells. Mol Med Rep. 6:1006–1012. 2012.PubMed/NCBI
|
16
|
Fan Y, Xin XY, Chen BL and Ma X: Knockdown
of RAB25 expression by RNAi inhibits growth of human epithelial
ovarian cancer cells in vitro and in vivo. Pathology. 38:561–567.
2006. View Article : Google Scholar
|
17
|
Wang H, Li H, Zuo M, et al: Lx2-32c, a
novel taxane and its antitumor activities in vitro and in vivo.
Cancer Lett. 268:89–97. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Goldenring JR and Nam KT: Rab25 as a
tumour suppressor in colon carcinogenesis. Br J Cancer. 104:33–36.
2011. View Article : Google Scholar :
|
19
|
Cheng KW, Lahad JP, Gray JW and Mills GB:
Emerging role of RAB GTPases in cancer and human disease. Cancer
Res. 65:2516–2519. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Casanova JE, Wang X, Kumar R, et al:
Association of Rab25 and Rab11a with the apical recycling system of
polarized Madin-Darby canine kidney cells. Mol Biol Cell. 10:47–61.
1999. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang X, Kumar R, Navarre J, Casanova JE
and Goldenring JR: Regulation of vesicle trafficking in madin-darby
canine kidney cells by Rab11a and Rab25. J Biol Chem.
275:29138–29146. 2000. View Article : Google Scholar : PubMed/NCBI
|
22
|
Fraser M, Leung B, Jahani-Asl A, Yan X,
Thompson WE and Tsang BK: Chemoresistance in human ovarian cancer:
the role of apoptotic regulators. Reprod Biol Endocrinol. 1:662003.
View Article : Google Scholar : PubMed/NCBI
|